Richard Lipkin, MBA
Richard Lipkin is a Co-Founder, Co-Chair, and Co-Manager of the Investment Committee of the Catalytic Impact Foundation (CIF). He is also a Managing Director of Easton Capital Investment Group, a NYC-based life sciences and healthcare venture capital firm; and a Co-Founder and Co-Chair of Princeton Alumni Angels. Through CIF, he also serves as a Board Director of Epivax Therapeutics and Ceretype Neuromedicine.
Previously, he served as a partner of Commerce Health Ventures, a life sciences and healthcare fund of NewSpring Capital; Laird & Company, a private merchant bank; and other private investment partnerships, including as a biotech analyst and consultant for a Goldman Sachs hedge fund.
Lipkin has studied cognitive and computational neuroscience at Columbia University and the Marine Biological Laboratory in Woods Hole, MA, and served on Columbia University Medical Center’s Health Sciences Advisory Council, Neuroscience Council, and Medical Science and Technology Council.
He has served as member of boards, councils, and committees for the Weizmann Institute of Science, the Israel Cancer Research Fund, Rockefeller University, Marine Biological Laboratory, Columbia University, the New York Academy of Sciences, and the Montefiore Medical Center. He is an honors graduate of Princeton University, has an MBA from Columbia Business School, and served as a Senior Staff Associate in Columbia University’s Zuckerman Institute of Mind, Brain, and Behavior.